Literature DB >> 18471215

Comparison of presumptive blood test kits including hexagon OBTI.

Emma Johnston1, Carole E Ames, Kathryn E Dagnall, John Foster, Barbara E Daniel.   

Abstract

Four presumptive blood tests, Hexagon OBTI, Hemastix(R), Leucomalachite green (LMG), and Kastle-Meyer (KM) were compared for their sensitivity in the identification of dried bloodstains. Stains of varying blood dilutions were subjected to each presumptive test and the results compared. The Hexagon OBTI buffer volume was also reduced to ascertain whether this increased the sensitivity of the kit. The study found that Hemastix(R) was the most sensitive test for trace blood detection. Only with the reduced buffer volume was the Hexagon OBTI kit as sensitive as the LMG and KM tests. However, the Hexagon OBTI kit has the advantage of being a primate specific blood detection kit. This study also investigated whether the OBTI buffer within the kit could be utilized for DNA profiling after presumptive testing. The results show that DNA profiles can be obtained from the Hexagon OBTI kit buffer directly.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18471215     DOI: 10.1111/j.1556-4029.2008.00727.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  3 in total

1.  Validation of an immunochromatographic D-dimer test to presumptively identify menstrual fluid in forensic exhibits.

Authors:  Hannah Holtkötter; Lisa Dierig; Marianne Schürenkamp; Ulla Sibbing; Heidi Pfeiffer; Marielle Vennemann
Journal:  Int J Legal Med       Date:  2014-11-05       Impact factor: 2.686

2.  Detectability, visualization, and DNA analysis of bloodstains after repainting the walls.

Authors:  Frank Ramsthaler; Julia Schlote; Axel Gehl; Sabine Cappel-Hoffmann; Mattias Kettner
Journal:  Int J Legal Med       Date:  2018-08-09       Impact factor: 2.686

3.  Mass spectrometry-based proteomics as a tool to identify biological matrices in forensic science.

Authors:  Katleen Van Steendam; Marlies De Ceuleneer; Maarten Dhaenens; David Van Hoofstat; Dieter Deforce
Journal:  Int J Legal Med       Date:  2012-07-29       Impact factor: 2.686

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.